Severe neurological toxicity of immune checkpoint inhibitors: growing spectrum

Migraine and Headache

Neurological adverse events associated with immune checkpoint inhibitors: Review of the literature

Eur J Cancer.

Cuzzubbo S, Javeri F, Tissier M, Roumi A, Barlog C, Doridam J, Lebbe C, Belin C, Ursu R, Carpentier AF

doi: 10.1016/j.ejca.2016.12.001.

Further Publications NeurologyFurther Publications Psychiatry

Neurotoxicity associated with cancer immunotherapy: immune checkpoint inhibitors and chimeric antigen receptor T-cell therapy

Curr Opin Neurol.

Perrinjaquet C, Desbaillets N, Hottinger AF

doi: 10.1097/WCO.0000000000000686.

Further Publications NeurologyFurther Publications Psychiatry

Immune Checkpoint Inhibitors for Brain Metastases: A Primer for Neurosurgeons

Neurosurgery.

Aquilanti E, Brastianos PK

doi: 10.1093/neuros/nyaa095.

Multiple Sclerosis

Cerebrospinal fluid biomarkers link toxic astrogliosis and microglial activation to multiple sclerosis severity

Mult Scler Relat Disord.

Masvekar R, Wu T, Kosa P, Barbour C, Fossati V, Bielekova B

doi: 10.1016/j.msard.2018.11.032.

Autism

Effects of Improvisational Music Therapy vs Enhanced Standard Care on Symptom Severity Among Children With Autism Spectrum Disorder: The TIME-A Randomized Clinical Trial

JAMA.

Bieleninik L, Geretsegger M, Mössler K, Assmus J, Thompson G, Gattino G, Elefant C, Gottfried T, Igliozzi R, Muratori F, Suvini F, Kim J, Crawford MJ, Odell-Miller H, Oldfield A, Casey Ó, Finnemann J, Carpente J, Park AL, Grossi E, Gold C; TIME-A Study Team

doi: 10.1001/jama.2017.9478.

Further Publications NeurologyFurther Publications Psychiatry

Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma

Nat Med.

Zhao J, Chen AX, Gartrell RD, Silverman AM, Aparicio L, Chu T, Bordbar D, Shan D, Samanamud J, Mahajan A, Filip I, Orenbuch R, Goetz M, Yamaguchi JT, Cloney M, Horbinski C, Lukas RV, Raizer J, Rae AI, Yuan J, Canoll P, Bruce JN, Saenger YM, Sims P, Iwamoto FM, Sonabend AM, Rabadan R

doi: 10.1038/s41591-019-0349-y.

Anxiety and Depression

Efficacy and Safety of Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, and Placebo for Common Psychiatric Disorders Among Children and Adolescents: A Systematic Review and Meta-analysis

JAMA Psychiatry.

Locher C, Koechlin H, Zion SR, Werner C, Pine DS, Kirsch I, Kessler RC, Kossowsky J

doi: 10.1001/

RECOMMENDED

Multiple SclerosisAnxiety and Depression

Comorbid anxiety, depression, and cognition in MS and other immune-mediated disorders

Neurology.

Whitehouse CE, Fisk JD, Bernstein CN, Berrigan LI, Bolton JM, Graff LA, Hitchon CA, Marriott JJ, Peschken CA, Sareen J, Walker JR, Stewart SH, Marrie RA; CIHR Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease

doi: 10.1212/WNL.

Further Publications Neurology

Real-life data for first-line combination immune-checkpoint inhibition and targeted therapy in patients with melanoma brain metastases

Eur J Cancer

Hilbers ML, Dimitriou F, Lau P, Bhave P, McArthur GA, Zimmer L, Kudura K, Gérard CL, Levesque MP, Michielin O, Dummer R, Cheng PF, Mangana J

doi: 10.1016/j.ejca.2021.07.028

Related content

Neurological adverse events associated with immune checkpoint inhibitors: Review of the literature

Neurotoxicity associated with cancer immunotherapy: immune checkpoint inhibitors and chimeric antigen receptor T-cell therapy

Immune Checkpoint Inhibitors for Brain Metastases: A Primer for Neurosurgeons

Cerebrospinal fluid biomarkers link toxic astrogliosis and microglial activation to multiple sclerosis severity

Effects of Improvisational Music Therapy vs Enhanced Standard Care on Symptom Severity Among Children With Autism Spectrum Disorder: The TIME-A Randomized Clinical Trial

Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma

Efficacy and Safety of Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, and Placebo for Common Psychiatric Disorders Among Children and Adolescents: A Systematic Review and Meta-analysis

Comorbid anxiety, depression, and cognition in MS and other immune-mediated disorders

Real-life data for first-line combination immune-checkpoint inhibition and targeted therapy in patients with melanoma brain metastases